‘I’ve been doing this for a long, long time. I think it’s a very rewarding thing to do.’

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/2b/35/38/2b3538c7-338a-f4b9-76bc-f3a1db3fb287/mza_9747440335057467958.jpg/600x600bb.jpg

The Venari Growth Podcast

Venari Partners

18 episodes

1 day ago

In this series our consultants speak to business leaders on how they are uncovering the pathways to profitable and strategic growth.

Careers

Business

RSS

All content for The Venari Growth Podcast is the property of Venari Partners and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

In this series our consultants speak to business leaders on how they are uncovering the pathways to profitable and strategic growth.

Careers

Business

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/42588354/42588354-1733317329845-9ae985b760739.jpg

‘I’ve been doing this for a long, long time. I think it’s a very rewarding thing to do.’ | Manfred Ruediger

The Venari Growth Podcast

14 minutes 44 seconds

1 year ago

‘I’ve been doing this for a long, long time. I think it’s a very rewarding thing to do.’ | Manfred Ruediger

‘I’ve been doing this for a long, long time. I think it’s a very rewarding thing to do.’

This episode of the Venari Podcast’s Talking Radiopharma series saw Matthew Palmer speak to Ariceum Therapeutics CEO Manfred Ruediger. A serial biotech entrepreneur, Manfred has worked in executive functions in biotech for almost 25 years.

Ariceum’s development of novel targeted radiopharmaceuticals for cancer treatment – as well as Manfred’s considerable experience building out companies – certainly offered plenty of scope for discussion. Tune in to hear more about what Ariceum do differently, plus Manfred’s thoughts on team building and his advice for the radiopharmaceutical innovators of tomorrow!

Our thanks to the Ariceum CEO and his team for this fascinating podcast.